PUBLISHER: IMARC | PRODUCT CODE: 1291421
PUBLISHER: IMARC | PRODUCT CODE: 1291421
The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. The growing number of drug traffickers and local dealers, rising cases of substance abuse, and increasing employment of virtual currencies represent some of the key factors driving the market.
Drug screening refers to the process of collecting and analyzing the blood, urine, hair, or saliva of an individual to detect the presence of contaminants and chemicals left behind due to drug usage. It comprises a wide variety of testing methods, such as enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is a superior and highly accurate drug confirmation test implemented on initial positive results. It is utilized for detecting the use and misuse of drugs, which includes illegal drugs, such as cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). It is also employed for detecting the misuse of various prescription medicines which are taken in a different way or in high doses. It is performed in various clinical trials of a drug to estimate the efficiency and safety of various novel drugs. Drug screening is also performed during legal prosecution for criminal law enforcement purposes. Furthermore, it is used in accessing abuse potential and adherence among various patients who are receiving opioid therapy.
At present, the increasing demand for drug screening as it is accurate and provides spontaneous results represents one of the primary factors influencing the market positively. Besides this, rising cases of substance abuse around the world are propelling the growth of the market. In addition, the growing utilization of drugs among the masses to cope with losses, stress, and anxiety is offering a favorable market outlook. Apart from this, the rising trends of clubbing, drinking alcohol, smoking, and doing drugs among young individuals due to peer pressure is contributing to the growth of the market. Additionally, governing agencies of various countries are undertaking initiatives to carry out regular roadside oral fluid screening to detect drug-impaired drivers. They are also launching substance abuse and addiction programs to help severe addicts and individuals suffering from drug abuse. Moreover, there is a rise in the number of drug traffickers and local dealers providing easy access of drugs to addicts. This, coupled with the increasing employment of virtual currencies that operate beyond the traditional financial system, granting improved anonymity to drug dealers and buyers across the globe is supporting the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, sample type and end user.
The report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.
A detailed breakup and analysis of the drug screening market based on the sample type has also been provided in the report. This includes urine samples, breath samples, oral fluid samples, hair samples, and others. According to the report, urine samples accounted for the largest market share.
A detailed breakup and analysis of the drug screening market based on the end user has also been provided in the report. This includes hospitals, drug testing laboratories, workplaces, drug treatment centers, pain management centers, personal users, and criminal justice system and law enforcement agencies. According to the report, workplaces accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening. Some of the factors driving the North America drug screening market included the growing cases of substance abusive, increasing number of drug dealers, rising black marketing of prescribed drugs, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.